Published in J Histochem Cytochem on July 20, 2012
Gene expression profiling identifies molecular pathways associated with collagen VI deficiency and provides novel therapeutic targets. PLoS One (2013) 1.44
Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem (2014) 1.32
Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J (2013) 1.22
An introduction to proteoglycans and their localization. J Histochem Cytochem (2012) 1.08
Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol (2014) 1.03
Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Biochim Biophys Acta (2015) 0.92
De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways. Matrix Biol (2013) 0.87
Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases. Fibrogenesis Tissue Repair (2013) 0.86
Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediators Inflamm (2014) 0.86
Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. Physiol Rev (2016) 0.85
Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression. Trends Cancer Res (2013) 0.85
Key roles for the small leucine-rich proteoglycans in renal and pulmonary pathophysiology. Biochim Biophys Acta (2014) 0.84
The plastic nature of the human bone-periodontal ligament-tooth fibrous joint. Bone (2013) 0.83
Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer. PLoS One (2013) 0.80
Soluble biglycan as a biomarker of inflammatory renal diseases. Int J Biochem Cell Biol (2014) 0.80
Absence of fibromodulin affects matrix composition, collagen deposition and cell turnover in healthy and fibrotic lung parenchyma. Sci Rep (2014) 0.80
Hydrogel scaffolds as in vitro models to study fibroblast activation in wound healing and disease. Biomater Sci (2014) 0.79
Recombinant fibromodulin has therapeutic effects on diabetic nephropathy by down-regulating transforming growth factor-β1 in streptozotocin-induced diabetic rat model. Iran J Basic Med Sci (2016) 0.78
Metabolism of cartilage proteoglycans in health and disease. Biomed Res Int (2014) 0.76
Contribution of Human Fibroblasts and Endothelial Cells to the Hallmarks of Inflammation as Determined by Proteome Profiling. Mol Cell Proteomics (2016) 0.76
The phenotype of the musculocontractural type of Ehlers-Danlos syndrome due to CHST14 mutations. Am J Med Genet A (2015) 0.76
Chronic UVB-irradiation actuates perpetuated dermal matrix remodeling in female mice: Protective role of estrogen. Sci Rep (2016) 0.75
A novel biological function of soluble biglycan: Induction of erythropoietin production and polycythemia. Glycoconj J (2016) 0.75
Dermatan sulfate is a player in the transglutaminase 2 interaction network. PLoS One (2017) 0.75
Early extracellular matrix changes are associated with later development of bronchiolitis obliterans syndrome after lung transplantation. BMJ Open Respir Res (2017) 0.75
Glycosylation of Dentin Matrix Protein 1 is critical for osteogenesis. Sci Rep (2015) 0.75
Inflammasomes in the urinary tract: a disease-based review. Am J Physiol Renal Physiol (2016) 0.75
The hepatic "matrisome" responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice. Hepatology (2016) 0.75
Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants. Int J Mol Sci (2017) 0.75
Synaptic Homeostasis and Its Immunological Disturbance in Neuromuscular Junction Disorders. Int J Mol Sci (2017) 0.75
Biglycan Inhibits Capsaicin-Induced Substance P Release by Cultured Dorsal Root Ganglion Neurons. Am J Phys Med Rehabil (2016) 0.75
Caveat Emptor: For Researchers, A Rose Will Not Smell Sweet Unless We Know Its Composition. Biosci Rep (2017) 0.75
The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3. Transl Stroke Res (2015) 0.75
Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 8.87
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature (2009) 6.67
NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol (2010) 5.90
Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med (2002) 5.70
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood (2011) 5.61
Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med (2007) 4.80
TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest (2007) 4.77
Regulation of inflammasome signaling. Nat Immunol (2012) 4.10
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest (2005) 3.99
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92
Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med (2009) 3.87
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature (2002) 3.80
Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol (2002) 3.32
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet (1998) 2.84
Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem (1990) 2.72
Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol (2007) 2.58
Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem (2008) 2.53
Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology (2002) 2.46
Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One (2012) 2.18
Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem (2009) 2.12
Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res (2002) 2.08
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest (2010) 2.07
Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J (2002) 2.05
Transforming growth factor-beta regulates production of proteoglycans by mesangial cells. Kidney Int (1990) 2.04
Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation (2007) 1.98
The role of small leucine-rich proteoglycans in collagen fibrillogenesis. Matrix Biol (2010) 1.91
Proteoglycans of developing bone. J Biol Chem (1983) 1.86
Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc Natl Acad Sci U S A (2011) 1.85
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J (2010) 1.83
Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem (2005) 1.82
Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J (2010) 1.82
Proteoglycans: from structural compounds to signaling molecules. Cell Tissue Res (2009) 1.80
Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem (2009) 1.79
The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J (2004) 1.74
Biglycan is required for adaptive remodeling after myocardial infarction. Circulation (2008) 1.72
Interaction of biglycan with type I collagen. J Biol Chem (1995) 1.63
Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathol (2010) 1.61
An expression signature classifies chemotherapy-resistant pediatric osteosarcoma. Cancer Res (2005) 1.60
WISP-1 is an osteoblastic regulator expressed during skeletal development and fracture repair. Am J Pathol (2004) 1.53
Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol (2002) 1.52
Characterization of the dermatan sulfate proteoglycans, DS-PGI and DS-PGII, from bovine articular cartilage and skin isolated by octyl-sepharose chromatography. J Biol Chem (1989) 1.51
Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal (2011) 1.50
Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin. FASEB J (2001) 1.45
Bone morphogenetic protein-1 processes probiglycan. J Biol Chem (2000) 1.45
Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscul Disord (1997) 1.43
Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest (1993) 1.40
Molecular interactions of biglycan and decorin with elastic fiber components: biglycan forms a ternary complex with tropoelastin and microfibril-associated glycoprotein 1. J Biol Chem (2001) 1.38
Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice. J Am Soc Nephrol (1999) 1.36
WISP-1 binds to decorin and biglycan. J Biol Chem (2001) 1.32
Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J (2003) 1.32
Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res (2002) 1.29
The small leucine-rich repeat proteoglycan biglycan binds to alpha-dystroglycan and is upregulated in dystrophic muscle. J Cell Biol (2000) 1.29
Targeting fibrosis in Duchenne muscular dystrophy. J Neuropathol Exp Neurol (2010) 1.27
Biglycan modulates osteoblast differentiation and matrix mineralization. J Bone Miner Res (2005) 1.26
The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal (2009) 1.25
Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci U S A (2010) 1.24
The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One (2009) 1.22
Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation. Mol Immunol (2008) 1.21
Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site. Arthritis Res Ther (2006) 1.19
Extracellular matrix molecules: endogenous danger signals as new drug targets in kidney diseases. Curr Opin Pharmacol (2010) 1.16
Mice deficient in biglycan and fibromodulin as a model for temporomandibular joint osteoarthritis. Cells Tissues Organs (2005) 1.16
Fibrillogenesis of collagen types I, II, and III with small leucine-rich proteoglycans decorin and biglycan. Biomacromolecules (2006) 1.16
Biglycan is a new extracellular component of the Chordin-BMP4 signaling pathway. EMBO J (2005) 1.15
The effect of stromelysin-1 (MMP-3) on non-collagenous extracellular matrix proteins of demineralized dentin and the adhesive properties of restorative resins. Biomaterials (2008) 1.15
Tumour necrosis factor-alpha interacts with biglycan and decorin. FEBS Lett (2002) 1.15
Impaired regeneration of dystrophin-deficient muscle fibers is caused by exhaustion of myogenic cells. Braz J Med Biol Res (2002) 1.15
Dermatan sulphate proteoglycans of human articular cartilage. The properties of dermatan sulphate proteoglycans I and II. Biochem J (1989) 1.15
Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis. Am J Pathol (2009) 1.13
Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. Curr Opin Genet Dev (2012) 1.11
Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle (2012) 1.11
Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech (2009) 1.11
Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Dev Biol (2004) 1.10
Non-proteoglycan forms of biglycan increase with age in human articular cartilage. Biochem J (1993) 1.08
Identification and characterization of glycanated and non-glycanated forms of biglycan and decorin in the human intervertebral disc. Biochem J (1993) 1.06
Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1. PLoS One (2012) 1.05
Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease. J Cell Mol Med (2006) 1.04
Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS. FASEB J (2006) 1.03
Biglycan is an extracellular MuSK binding protein important for synapse stability. J Neurosci (2012) 1.02
Decorin and biglycan expression is differentially altered in several muscular dystrophies. Brain (2005) 1.01
Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biol (2008) 1.01
Transcriptional regulation of the human biglycan gene. J Biol Chem (1996) 1.00
Regulation, regulatory activities, and function of biglycan. Crit Rev Eukaryot Gene Expr (2004) 0.98
Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int (2000) 0.98
Small leucine-rich proteoglycans in kidney disease. J Am Soc Nephrol (2011) 0.95
Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation. Adv Exp Med Biol (2006) 0.94
Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development. J Cell Physiol (2006) 0.94
Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2. Am J Pathol (2010) 0.94
Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int (1998) 0.94
Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases. Rheumatology (Oxford) (2003) 0.93
Altered matrix production in the distal airways of individuals with asthma. Thorax (2010) 0.93
Differences in proteoglycan deposition in the airways of moderate and severe asthmatics. Eur Respir J (2006) 0.92
Expression of biglycan, decorin and proteoglycan-100/CSF-1 in normal and fibrotic human liver. Pathol Res Pract (1997) 0.92
The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J Immunol (2011) 0.92
Up-regulated biglycan expression correlates with the malignancy in human colorectal cancers. Clin Exp Med (2011) 0.91
Colorectal cancer desmoplastic reaction up-regulates collagen synthesis and restricts cancer cell invasion. Cell Tissue Res (2011) 0.91
Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. Exp Biol Med (Maywood) (2011) 0.90
The potential functional interaction of biglycan and WISP-1 in controlling differentiation and proliferation of osteogenic cells. Cells Tissues Organs (2008) 0.90
Non-enzymatic decomposition of collagen fibers by a biglycan antibody and a plausible mechanism for rheumatoid arthritis. PLoS One (2012) 0.90
Differences in extracellular matrix production and basic fibroblast growth factor response in skin fibroblasts from sporadic and familial Alzheimer's disease. Mol Med (2007) 0.90
Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med (2007) 4.80
SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature (2011) 4.14
The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest (2005) 3.99
WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J Clin Invest (2009) 3.33
Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology (2002) 2.46
Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem (2009) 2.12
The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest (2010) 2.07
Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J (2002) 2.05
The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int (2005) 2.02
Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation (2007) 1.98
deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene (2003) 1.92
Modulation of canonical Wnt signaling by the extracellular matrix component biglycan. Proc Natl Acad Sci U S A (2011) 1.85
Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem (2005) 1.82
Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycans. FEBS J (2010) 1.82
Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem (2009) 1.79
The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation. FASEB J (2004) 1.74
Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol (2012) 1.73
The effect of 3D hydrogel scaffold modulus on osteoblast differentiation and mineralization revealed by combinatorial screening. Biomaterials (2010) 1.71
Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression. Kidney Int (2009) 1.62
Decorin, a novel player in the insulin-like growth factor system. J Biol Chem (2005) 1.59
Osteoblast-related transcription factors Runx2 (Cbfa1/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res (2003) 1.57
Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific. Bone (2007) 1.52
Signaling by the matrix proteoglycan decorin controls inflammation and cancer through PDCD4 and MicroRNA-21. Sci Signal (2011) 1.50
A primer on iron therapy. Nephrol Dial Transplant (2007) 1.48
Decorin: a guardian from the matrix. Am J Pathol (2012) 1.46
KIBRA modulates directional migration of podocytes. J Am Soc Nephrol (2008) 1.36
Decorin deficiency leads to impaired angiogenesis in injured mouse cornea. J Vasc Res (2004) 1.29
Age-related osteoporosis in biglycan-deficient mice is related to defects in bone marrow stromal cells. J Bone Miner Res (2002) 1.29
Role of Nox4 in murine models of kidney disease. Free Radic Biol Med (2012) 1.28
Animal models of osteoarthritis: lessons learned while seeking the "Holy Grail". Curr Opin Rheumatol (2006) 1.27
The matricellular functions of small leucine-rich proteoglycans (SLRPs). J Cell Commun Signal (2009) 1.25
The determination of stem cell fate by 3D scaffold structures through the control of cell shape. Biomaterials (2011) 1.25
WISP-1/CCN4 regulates osteogenesis by enhancing BMP-2 activity. J Bone Miner Res (2011) 1.23
Decorin causes autophagy in endothelial cells via Peg3. Proc Natl Acad Sci U S A (2013) 1.22
Biological interplay between proteoglycans and their innate immune receptors in inflammation. FEBS J (2013) 1.22
In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. FASEB J (2003) 1.22
Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem (2011) 1.20
Mice deficient in biglycan and fibromodulin as a model for temporomandibular joint osteoarthritis. Cells Tissues Organs (2005) 1.16
Modulus-driven differentiation of marrow stromal cells in 3D scaffolds that is independent of myosin-based cytoskeletal tension. Biomaterials (2010) 1.14
Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis. Am J Pathol (2009) 1.13
Impact on bone of an estrogen receptor-alpha gene loss of function mutation. J Clin Endocrinol Metab (2008) 1.12
Fibromodulin-deficient mice display impaired collagen fibrillogenesis in predentin as well as altered dentin mineralization and enamel formation. J Histochem Cytochem (2005) 1.11
Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal disease. PLoS One (2010) 1.11
Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle (2012) 1.11
Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech (2009) 1.11
Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Dev Biol (2004) 1.10
Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype. J Biol Chem (2011) 1.10
Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model. PLoS One (2012) 1.09
The mechanical phenotype of biglycan-deficient mice is bone- and gender-specific. Bone (2006) 1.09
The biology of small leucine-rich proteoglycans in bone pathophysiology. J Biol Chem (2012) 1.04
Molecular mechanisms of TGF beta receptor-triggered signaling cascades rapidly induced by the calcineurin inhibitors cyclosporin A and FK506. J Immunol (2008) 1.03
TGF-beta1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function. J Cell Biochem (2008) 1.03
Regulation of fibrillin-1 by biglycan and decorin is important for tissue preservation in the kidney during pressure-induced injury. Am J Pathol (2004) 1.03
Biglycan is an extracellular MuSK binding protein important for synapse stability. J Neurosci (2012) 1.02
Regulation, regulatory activities, and function of biglycan. Crit Rev Eukaryot Gene Expr (2004) 0.98
Variation in mineral properties in normal and mutant bones and teeth. Cells Tissues Organs (2005) 0.98
Combinatorial screening of osteoblast response to 3D calcium phosphate/poly(ε-caprolactone) scaffolds using gradients and arrays. Biomaterials (2010) 0.98
CXCL16 and oxLDL are induced in the onset of diabetic nephropathy. J Cell Mol Med (2009) 0.96
Regeneration of bone and periodontal ligament induced by recombinant amelogenin after periodontitis. J Cell Mol Med (2009) 0.96
WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone. PLoS One (2013) 0.95
Genetic evidence for key roles of decorin and biglycan in dentin mineralization. Matrix Biol (2009) 0.94
Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development. J Cell Physiol (2006) 0.94
The proteoglycan biglycan enhances antigen-specific T cell activation potentially via MyD88 and TRIF pathways and triggers autoimmune perimyocarditis. J Immunol (2011) 0.92
Absence of biglycan accelerates the degenerative process in mouse intervertebral disc. Spine (Phila Pa 1976) (2009) 0.92
Platelet-derived growth factor-BB induces cystathionine γ-lyase expression in rat mesangial cells via a redox-dependent mechanism. Br J Pharmacol (2012) 0.91
Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone (2005) 0.91
The potential functional interaction of biglycan and WISP-1 in controlling differentiation and proliferation of osteogenic cells. Cells Tissues Organs (2008) 0.90
Comparative proteomic analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF) and lung transplant donor lungs. J Proteome Res (2011) 0.90
Biglycan deficiency interferes with ovariectomy-induced bone loss. J Bone Miner Res (2003) 0.90
Gene expression profile of human bone marrow stromal cells: high-throughput expressed sequence tag sequencing analysis. Genomics (2002) 0.89
Fibromodulin-deficient mice reveal dual functions for fibromodulin in regulating dental tissue and alveolar bone formation. Cells Tissues Organs (2008) 0.89
Freeform fabricated scaffolds with roughened struts that enhance both stem cell proliferation and differentiation by controlling cell shape. Biomaterials (2012) 0.89
Renal accumulation of biglycan and lipid retention accelerates diabetic nephropathy. Am J Pathol (2011) 0.88
Nephronectin regulates atrioventricular canal differentiation via Bmp4-Has2 signaling in zebrafish. Development (2011) 0.87
Nanofiber scaffold gradients for interfacial tissue engineering. J Biomater Appl (2012) 0.87
Unilateral dampening of Bmp activity by nodal generates cardiac left-right asymmetry. Dev Cell (2013) 0.86
Unilateral nephrectomy leads to up-regulation of syndecan-2- and TGF-beta-mediated glomerulosclerosis in syndecan-4 deficient male mice. Matrix Biol (2007) 0.85
Impaired posterior frontal sutural fusion in the biglycan/decorin double deficient mice. Bone (2006) 0.85
A physiologic three-dimensional cell culture system to investigate the role of decorin in matrix organisation and cell survival. Biochem Biophys Res Commun (2005) 0.84
Nitric oxide upregulates induction of PDGF receptor-alpha expression in rat renal mesangial cells and in anti-Thy-1 glomerulonephritis. J Am Soc Nephrol (2005) 0.83
Role of fibrillin-1 in hypertensive and diabetic glomerular disease. Am J Physiol Renal Physiol (2005) 0.82
Fabricating gradient hydrogel scaffolds for 3D cell culture. Comb Chem High Throughput Screen (2011) 0.81
Tendon functional extracellular matrix. J Orthop Res (2015) 0.81
Essential contribution of tumor-derived perlecan to epidermal tumor growth and angiogenesis. J Histochem Cytochem (2004) 0.81
Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1. J Am Soc Nephrol (2009) 0.81
Transcriptional regulation restricting bone sialoprotein gene expression to both hypertrophic chondrocytes and osteoblasts. J Cell Biochem (2002) 0.79
Dissection of the sets of genes that control the behavior of biglycan-deficient pre-osteoblasts using oligonucleotide microarrays. Bone (2005) 0.79
Reversibility of renal injury with cholesterol lowering in hyperlipidemic diabetic mice. J Lipid Res (2010) 0.79
Catabolism of newly synthesized decorin in vitro by human peritoneal mesothelial cells. Perit Dial Int (2004) 0.77
OxLDL inhibits LPS-induced IFNβ expression by Pellino3- and IRAK1/4-dependent modification of TANK. Cell Signal (2012) 0.76
Expression of transcription factors and matrix genes in response to serum stimulus in vascular smooth muscle cells. Eur J Cell Biol (2003) 0.76
The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3. Transl Stroke Res (2015) 0.75
Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti-inflammatory activities in vitro and in vivo. J Cell Mol Med (2015) 0.75
Extracellular Matrix Mediates BMP-2 in a Model of Temporomandibular Joint Osteoarthritis. Cells Tissues Organs (2017) 0.75
Coagulation factor XII regulates inflammatory responses in human lungs. Thromb Haemost (2017) 0.75